Basic Information
| LncRNA/CircRNA Name | circLMTK2 |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | exosome | ||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qPCR, western blot |
| Sample | gastric carcinoma tissue,cell line(MGC-803) |
| Expression Pattern | up-regulated |
| Function Description | Afterward, overexpression of circLMTK2 was performed in gastric cancer cell line MGC-803, and results indicated that malignant biological properties were inhibited by circLTMK2 overexpression. |
| Pubmed ID | 30988068 |
| Year | 2019 |
| Title | CircLMTK2 acts as a novel tumor suppressor in gastric cancer. |
External Links
| Links for circLMTK2 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |